CCO Podcasts
Regional Therapy for HCC: Patient Selection and Management Issues
|
|
Melanie B. Thomas MD, MS, and other expert CCO expert faculty members review and explore regional treatment strategies for the clinical management of patients with HCChepatocellular carcinoma.
Date posted: 2/24/2009
| Duration: 30:42
|
Systemic Therapy and Multidisciplinary Supportive Care in Patients With Advanced HCC
|
|
Alan P. Venook, MD, and other CCO expert faculty members discuss systemic treatment options for the clinical management of patients with hepatocellular carcinoma.
Date posted: 2/24/2009
| Duration: 24:27
|
Expert Highlight: Gastrointestinal Cancers
|
|
Date posted: 12/31/2008
| Duration: 8:56
|
Expert Highlight: Lung Cancer
Expert Highlight: Hematologic Malignancies
|
|
Date posted: 12/31/2008
| Duration: 5:29
|
Expert Highlight: Breast Cancer
|
|
Kathy D. Miller, MD, provides an update on the top issues in adjuvant therapy including hormone therapy, bone loss treatments, and vitamin D status. She also discusses the impact of biologic agents targeting VEGF and EGFR on therapy for metastatic disease. (12 minutes)
Date posted: 12/31/2008
| Duration: 12:03
|
Expert Highlight: Genitourinary Cancers
|
|
Date posted: 12/31/2008
| Duration: 7:52
|
Expert Highlight: Acute Leukemias and Myelodysplastic Syndromes
|
|
Hagop Kantarjian, MD, provides an update of presentations on acute myeloid leukemia, myelodysplastic syndromes, and myelofibrosis.
Date posted: 12/13/2008
| Duration: 9:16
|
Updates in CLL
|
|
Kanti Rai, MD, discusses updates in CLL therapies, including lenalidomide in the frontline setting, FCR data from the REACH trial, and the novel agent ofatumumab.
Date posted: 12/13/2008
| Duration: 12:49
|
Expert Highlight: ESAs in Cancer
|
|
David P. Steensma, MD, describes a patient-level meta-analysis on the effect of ESAs on the survival of cancer patients and the implications for patient care.
Date posted: 12/13/2008
| Duration: 8:29
|
Expert Highlight: Lymphomas
|
|
Steven Bernstein, MD, summarizes the clinical advances in improving outcomes in patients with non-Hodgkin’s lymphomas, in particular T-cell lymphomas and mantle cell lymphomas.
Date posted: 12/12/2008
| Duration: 7:13
|
Updates Multiple Myeloma
|
|
Date posted: 12/11/2008
| Duration: 5:14
|
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
|
Featured Content
View Virtual Presentations and slidesets on transplantation in AML and MDS.
Review new treatment options and clinical considerations for non-Hodgkin’s lymphomas.
Explore the role of predictive biomarkers in individualized treatment of patients with colorectal cancer.
In a CME-certified video, Howard Liebman, MD, reviews the pathology and treatment of ITP.
|
|